DSS, Inc. (NYSEAMERICAN:DSS – Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 34,400 shares, a growth of 160.6% from the December 15th total of 13,200 shares. Based on an average daily trading volume, of 38,500 shares, the short-interest ratio is presently 0.9 days. Currently, 1.9% of the company’s shares are sold short.
Insider Buying and Selling at DSS
In other DSS news, Director Heng Fai Ambrose Chan bought 205,149 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $0.97 per share, for a total transaction of $198,994.53. Following the transaction, the director now owns 1,184,475 shares of the company’s stock, valued at approximately $1,148,940.75. The trade was a 20.95 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 59.30% of the company’s stock.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in DSS stock. Ferguson Wellman Capital Management Inc. acquired a new position in shares of DSS, Inc. (NYSEAMERICAN:DSS – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 25,501 shares of the business services provider’s stock, valued at approximately $32,000. Ferguson Wellman Capital Management Inc. owned 0.36% of DSS as of its most recent SEC filing. Institutional investors own 53.33% of the company’s stock.
DSS Trading Down 5.0 %
DSS Company Profile
DSS, Inc operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products.
Featured Stories
- Five stocks we like better than DSS
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- How Do Stock Buybacks Affect Shareholders?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for DSS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DSS and related companies with MarketBeat.com's FREE daily email newsletter.